ORIGINAL ARTICLE: Glycation Endproducts, Soluble Receptor for Advanced Glycation Endproducts and Cytokines in Diabetic and Non‐diabetic Pregnancies
- 11 January 2009
- journal article
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 61 (2), 175-182
- https://doi.org/10.1111/j.1600-0897.2008.00679.x
Abstract
Cytokines, advanced glycation end products (AGEs), and their receptor RAGE have been recently suggested to play a role in human pregnancy. In this study, we sought to determine the alterations of plasma AGEs, soluble RAGE (sRAGE), and proinflammatory cytokines in normal pregnancies and those complicated with type 1 diabetes mellitus. These parameters were measured in samples from healthy non-pregnant (C), diabetic non-pregnant (D), healthy pregnant (HP), and pregnant diabetic (DP) women. In the first trimester, DP showed lower sRAGE and higher AGEs compared to HP. In the DP group, significant negative correlations were seen between TNF-alpha and lipopolysaccharide (LPS)-stimulated IotaL-6 in the first trimester and sRAGE in the third trimester. LPS-stimulated IL-12 was positively correlated with levels of AGEs in the third trimester. We detected several differences in the levels of AGEs, sRAGE, and proinflammatory cytokines between euglycemic and diabetic pregnancies.Keywords
This publication has 23 references indexed in Scilit:
- Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammationjpme, 2008
- Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot studyjpme, 2008
- Advanced glycation endproducts mediate pro-inflammatory actions in human gestational tissues via nuclear factor-κB and extracellular signal-regulated kinase 1/2Journal of Endocrinology, 2007
- The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammationAmerican Journal of Obstetrics and Gynecology, 2007
- Aberrant Uterine Natural Killer (NK)‐Cell Expression and Altered Placental and Serum Levels of the NK‐Cell Promoting Cytokine Interleukin‐12 in Pre‐EclampsiaAmerican Journal of Reproductive Immunology, 2006
- Signal transduction pathways in mouse microglia N‐11 cells activated by advanced glycation endproducts (AGEs)Journal of Neurochemistry, 2003
- The Receptor for Advanced Glycation End Products (RAGE) Is Elevated in Women with PreeclampsiaHypertension in Pregnancy, 2003
- Infection and prematurity and the role of preventive strategiesSeminars in Neonatology, 2002
- Effects of pregnancy and exercise on concentrations of the metabolic markers tumor necrosis factor α and leptinAmerican Journal of Obstetrics and Gynecology, 2000
- Circulating bioactive tumor necrosis factor-α, tumor necrosis factor-α receptors, fibronectin, and tumor necrosis factor-α inducible cell adhesion molecule VCAM-1 in uncomplicated pregnancyAmerican Journal of Obstetrics and Gynecology, 1997